Wells Fargo analyst Steve Baxter maintained a Buy rating on Humana (HUM – Research Report) today and set a price target of $315.00. The ...

Clover Health’s 32% dip following its Q3 earnings could be an opportunity to accumulate shares. Find out why I’m reiterating ...

Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2024 investor letter. A ...

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” third-quarter 2024 investor letter. A ...

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” third-quarter 2024 investor letter. A ...

U.S. stocks slipped as juice ran out for the torrid “Trump trade” that swept Wall Street following Donald Trump’s ...

On Monday, Humana Inc (HUM) stock saw a decline, ending the day at $282.44 which represents a decrease of $-5.68 or -1.97% from the prior close of $288.12. The stock opened at $273 and touched a low ...

Markets have been performing well since Wednesday, when Donald Trump won the U.S. presidential election, leading Republicans ...

Asian shares are trading lower, despite a rally on Wall Street in stocks seen as benefiting the most from Donald Trump’s ...

U.S. stocks rose Monday, led by those seen as benefiting the most from Donald Trump's reelection as president, but drops for ...

Cigna Group confirmed it is "not pursuing a combination with Humana, a big provider of Medicare Advantage coveage.